CH455752A - Verfahren zur Herstellung neuer ungesättigter Amine - Google Patents

Verfahren zur Herstellung neuer ungesättigter Amine

Info

Publication number
CH455752A
CH455752A CH662963A CH662963A CH455752A CH 455752 A CH455752 A CH 455752A CH 662963 A CH662963 A CH 662963A CH 662963 A CH662963 A CH 662963A CH 455752 A CH455752 A CH 455752A
Authority
CH
Switzerland
Prior art keywords
production
unsaturated amines
new unsaturated
new
amines
Prior art date
Application number
CH662963A
Other languages
English (en)
Inventor
Ferdinand Huebner Charles
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of CH455752A publication Critical patent/CH455752A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH662963A 1962-06-19 1963-05-28 Verfahren zur Herstellung neuer ungesättigter Amine CH455752A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20343662A 1962-06-19 1962-06-19
US21189462A 1962-07-23 1962-07-23
US267810A US3253037A (en) 1962-06-19 1963-03-25 N-2-alkynyl-amino-benzocylo-alkanes

Publications (1)

Publication Number Publication Date
CH455752A true CH455752A (de) 1968-05-15

Family

ID=27394548

Family Applications (3)

Application Number Title Priority Date Filing Date
CH662963A CH455752A (de) 1962-06-19 1963-05-28 Verfahren zur Herstellung neuer ungesättigter Amine
CH1213866A CH466269A (de) 1962-06-19 1963-05-28 Verfahren zur Herstellung ungesättigter Amine
CH1213966A CH462154A (de) 1962-06-19 1963-05-28 Verfahren zur Herstellung neuer ungesättigter Amine

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1213866A CH466269A (de) 1962-06-19 1963-05-28 Verfahren zur Herstellung ungesättigter Amine
CH1213966A CH462154A (de) 1962-06-19 1963-05-28 Verfahren zur Herstellung neuer ungesättigter Amine

Country Status (10)

Country Link
US (1) US3253037A (de)
AT (2) AT244331B (de)
BE (1) BE633762A (de)
BR (1) BR6349933D0 (de)
CH (3) CH455752A (de)
DE (1) DE1443599A1 (de)
ES (1) ES289141A1 (de)
FR (1) FR3290M (de)
GB (1) GB1003686A (de)
SE (3) SE317370B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187017A (en) * 1966-07-16 1970-04-08 Aspro Nicholas Ltd Substituted 1-Amino Indanes and Tetrahydronaphthalens
US3485874A (en) * 1966-05-04 1969-12-23 Chinoin Gyogyszer Es Vegyeszet Ortho and para bromophenyl isopropyl methylamines
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
FR2319332A1 (fr) * 1975-07-28 1977-02-25 Roussel Uclaf Nouveaux derives de l'aminobenzocycloheptene et leurs sels, procede de preparation et application a titre de medicaments desdits produits
US4320148A (en) * 1980-11-24 1982-03-16 Smithkline Corporation 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
US4542153A (en) * 1981-05-06 1985-09-17 The Ohio State University Research Foundation Methods for changing calcium metabolism within the cells of a mammal
US4393226A (en) * 1981-05-06 1983-07-12 The Ohio State University Research Foundation Compounds and methods for changing calcium metabolism within the cells of a mammal
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
ZA901277B (en) * 1989-02-27 1991-10-30 Lilly Co Eli Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
IL92952A (en) * 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
IL99759A (en) * 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
CA2180841C (en) * 1994-01-10 2007-03-27 Sasson Cohen 1-aminoindan derivatives and compositions thereof
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
IL130528A (en) 1996-12-18 2004-12-15 Teva Pharma Aminoindan derivatives, pharmaceutical compositions comprising them and uses thereof
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
CN101300006B (zh) * 2005-06-02 2012-07-25 叶林发现公司 用于治疗肥胖的mao-b抑制剂
US7491847B2 (en) 2005-11-17 2009-02-17 Teva Pharmaceutical Industries, Ltd. Methods for isolating propargylated aminoindans
AU2006326642B2 (en) * 2005-12-09 2012-05-03 Technion Research And Development Foundation Ltd. Use of low-dose ladostigil for neuroprotection
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
EP2053033A1 (de) 2007-10-26 2009-04-29 Bayer Schering Pharma AG Verbindungen zur Verwendung bei der Abbildung, Diagnose und/oder Behandlung von Erkrankungen des zentralen Nervensystems oder von Tumoren
KR101523195B1 (ko) 2007-12-24 2015-05-27 시플라 리미티드 프로파길화된 아미노인단 유도체의 합성방법
EA201170181A1 (ru) * 2008-07-11 2011-08-30 Синтон Бв Полиморфные формы разагилина гидрохлорида
WO2010059913A2 (en) * 2008-11-20 2010-05-27 Dr. Reddy's Laboratories Ltd. Preparation of rasagiline and salts thereof
EP2451771B1 (de) * 2009-07-09 2014-06-18 Ratiopharm GmbH Rasagilin-salze und pharmazeutische zubereitungen daraus
EP2325159A1 (de) 2009-11-24 2011-05-25 LEK Pharmaceuticals d.d. Neuartige Salze von Rasagilin
EP2610239A1 (de) 2012-01-02 2013-07-03 Dr. Reddy's Laboratories Ltd. Herstellung von Rasagilin-Hemitartrat
AU2017257151A1 (en) * 2016-04-29 2018-11-15 Board Of Regents, The University Of Texas System Sigma receptor binders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201470A (en) * 1965-08-17 Chsx c cech

Also Published As

Publication number Publication date
BR6349933D0 (pt) 1973-08-28
CH466269A (de) 1968-12-15
BE633762A (fr) 1963-12-18
SE321676B (de) 1970-03-16
DE1443599A1 (de) 1968-10-24
CH462154A (de) 1968-09-15
GB1003686A (en) 1965-09-08
FR3290M (fr) 1965-05-03
SE317370B (de) 1969-11-17
SE321926B (de) 1970-03-23
US3253037A (en) 1966-05-24
ES289141A1 (es) 1963-11-16
AT244331B (de) 1965-12-27
AT244951B (de) 1966-02-10

Similar Documents

Publication Publication Date Title
CH462154A (de) Verfahren zur Herstellung neuer ungesättigter Amine
CH468967A (de) Verfahren zur Herstellung von Aminen
CH353732A (de) Verfahren zur Herstellung wasserunlöslicher tertiärer Amine
CH465640A (de) Verfahren zur Herstellung neuer Amine
CH435261A (de) Verfahren zur Herstellung neuer 19-Nor-androstene
CH437278A (de) Verfahren zur Herstellung neuer Oestranderivate
CH398636A (de) Verfahren zur Herstellung neuer Amine
CH405292A (de) Verfahren zur Herstellung neuer Homo-Steroide
AT191869B (de) Verfahren zur Herstellung neuer, tertiärer Amine
CH421137A (de) Verfahren zur Herstellung neuer Amine
AT248032B (de) Verfahren zur Herstellung neuer 3α-Phenyl-granatan-Derivate
AT242864B (de) Verfahren zur Herstellung neuer Acylamino-cephalosporansäuren
CH465588A (de) Verfahren zur Herstellung neuer ungesättigter Amine
CH465586A (de) Verfahren zur Herstellung neuer ungesättigter Amine
CH465643A (de) Verfahren zur Herstellung neuer Amine
CH429715A (de) Verfahren zur Herstellung neuer 4-Halogen-androstene
AT239254B (de) Verfahren zur Herstellung neuer, geschmackfreier Alkylamin-Salze des N-(5-Nitrofurfuryliden)-1-aminohydantoins
CH433359A (de) Verfahren zur Herstellung neuer 3a-Phenyl-granatan-Derivate
CH448127A (de) Verfahren zur Herstellung von Aminen
CH409574A (de) Verfahren zur Herstellung eines Halbleiter-Bauelementes
CH465646A (de) Verfahren zur Herstellung neuer sekundärer Amine
CH374667A (de) Verfahren zur Herstellung tertiärer Amine
CH440264A (de) Verfahren zur Herstellung neuer B-Homo-steroiden
AT248694B (de) Verfahren zur Herstellung neuer Telomerisate
CH411671A (de) Verfahren zur Herstellung eines Beton-Kies-Ersatzes